The mechanism of the immunity against plague has been one of the important and interesting problems in the study of plague. In general, there have been employed two kinds of antiplague vaccines for active immunization of human beings in the world, that is, the dead vaccine and the live vaccine.
The problem which is more effective and safer is regarded as important, but it has not been solved yet to give a clearcut conclusion. It seems that this problem may comprise three criteria to be fulfiled, first of all, before being answered.
The first point is whether there may be any probability that the avirulent protective strains employed for live vaccine can revert to the virulent bacilli.
The second point is which antigenic component (or components) plays the main and determinant role in the enhancement of virulence and in protective power. If such antigen were found, it may be possible to protect against plague by vaccinating with the antigen.
The third point is the presumption that the vaccination with live avirulent bacilli may have such potentialities on the site of interactions with host cells that may not be expectable from the vaccination with killed bacilli. Namely, it would be assumable that the live avirulent bacilli can affect host cells in some way, while they are multiplying and disseminating in the host.
Concerning the second point, the studies of Meyer and his associates on the envelope antigen,
i. e., Fraction I, (Meyer, 1950; Baker
et al., 1951) and the studies of Burrows
et al, on the V and W antigens (Burrows and Bacon, 1956) and the antigen responsible for the pigmentation of colonies on heamin or Fecontaining media (Jackson and Burrows, 1956a, b) seem to represent two main directions of the research.
According to Meyer, Fraction I was decisively protective for mice and rats against infection of fully virulent plague strains. Later reports confirmed the effectiveness of Fraction I for the protection of monkeys (Meyer
et al., 1948, cited in Girard, 1955) .
Fraction I had nest been believed to protect guinea pigs, until the report appeared in 1958 (Spivack
et al., 1958) informing that a relatively small amount of Fraction I protected guinea pigs against infection of fully virulent bacilli but too much Fraction I did not, and such a phenomenon could be interpreted by immunoparalysis.
On the other hand, Kasuga (1945) reported that live vaccine made of strain MII40 protected guinea pigs completely against infection of fully virulent plague strains and its prophylactic applications to the human proved striking effectiveness in the epidemic of plague in Manchuria (Kasuga, 1946 b) .
This strain, MII40, was isolated from the iliacal lymph node of a killed
Citellus mongolicus 25 days after inoculation of an envelope-rich and fully virulent strain, Mieguchi. The animal had hibernated when inoculated with strain Mieguchi, and was awaked 11 days after inoculation.
According to Kasuga we have possibility to reproduce the isolation of bacilli resembling to strain MII40 by inoculating virulent bacilli into immunized animals. Thus it would be reasonable to regard strain MII40 rather as a representative strain of such a group or a variety of strains of
P. pestis as has characteristics described by Kasuga than as a particular strain. Kasuga also stated that strain MII40 was lacking in the envelope antigen when examined by India ink method and by the cross precipitation test with the absorbed sera.
If this is true, the remarkably strong protective power of strain MII40 for guinea pigs cannot be explained by Fraction I.
In the preceding report (Wake, 1959 a) was described the third colonial form which had neither Fraction I nor toxin.
抄録全体を表示